Cancer Genetics: 3Q Earnings Snapshot

November 19, 2018

RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Monday reported a loss of $8.5 million in its third quarter.

On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 31 cents. Losses, adjusted for restructuring costs and costs related to mergers and acquisitions, came to 23 cents per share.

The diagnostics company posted revenue of $5.9 million in the period.

In the final minutes of trading on Monday, the company’s shares hit 45 cents. A year ago, they were trading at $2.70.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGIX at https://www.zacks.com/ap/CGIX

Update hourly